0.95Open1.10Pre Close34 Volume103 Open Interest70.00Strike Price1.23KTurnover1430.51%IV-0.21%PremiumNov 1, 2024Expiry Date0.35Intrinsic Value100Multiplier0DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type0.5848Delta0.2640Gamma351.75Leverage Ratio-375.0046Theta0.0000Rho205.69Eff Leverage0.0004Vega
DexCom Stock Discussion
Revenue came in at $994.2 million, topping the forecast of $990.71 million and showing growth from last year's $975 million.
The company announced that Teri Lawver, EVP and Chief Commercial Officer, will retire by year-end, with CEO Kevin Sayer temporarily leading the commercial team.
DexCom reaffirmed its 2024 sales outl...
Great products sells itself, ask novo disk and how they sell ozempic
No comment yet